Advertisement

Comparative Efficacies of Doxorubicin Complexes with Dextran Phosphate and Dextran Sulfate for Intracavity Chemotherapy of Zajdela Ascitic Hepatoma in Rats

  • O. V. Minaeva
  • A. V. Kokorev
  • P. S. Petrov
  • O. A. Kulikov
  • A. V. ZaborovskiiEmail author
  • K. G. Gurevich
  • L. A. Tararina
  • D. V. Yunina
  • A. M. Fedina
  • E. V. Gromova
  • M. N. Zharkov
  • E. P. Brodovskaya
  • N. A. Pyataev
Article

The efficacies of doxorubicin (Dox) complexes with carbohydrate polymers dextran phosphate (DP) and dextran sulfate (DS) in rats with grafted Zajdela ascitic hepatoma were studied in two series of experiments. The first studied the effects of the synthesized complexes on the cure rate and lifespan of the animals; the second, effects on ascites morphological parameters and Dox concentration in ascites fluid. The complexes were injected i.p. at a dose of 2 mg Dox/kg. The results showed that the Dox-DS complex reduced the lethality by 50% as compared with water-soluble Dox; the Dox-DP complex, by 28%. These complexes decreased statistically significantly the amount of ascites fluid and tumor-cell concentration in it. The drug was detected in ascites fluid 2 d after administration of Dox-DS and Dox-DP. The concentration of active ingredient in ascites fluid in animals treated with Dox-DS was >4 times higher than that in those treated with Dox-DP.

Keywords

dextran sulfate dextran phosphate doxorubicin intracavity chemotherapy Zajdela ascitic hepatoma 

Notes

Acknowledgments

The work was sponsored by the RFBR (Project No. 18-315-00250 mol_a).

References

  1. 1.
    P. Boffetta, Ann. Oncol., No. 18, 985 – 990 (2007).Google Scholar
  2. 2.
    A. N. Husain, T. V. Colby, N. G. Ordonez, et al., Arch. Pathol. Lab. Med., 142(1), 89 – 108 (2018).CrossRefGoogle Scholar
  3. 3.
    B. I. Hiddinga, V. F. Surmont, and J. P. Van Meerbeeck, Panminerva Med., 55(2), 157 – 173 (2013).Google Scholar
  4. 4.
    S. Tomek, S. Emri, K. Krejcy, et al., Br. J. Cancer, 88(2), 167 – 174 (2003).CrossRefGoogle Scholar
  5. 5.
    E. Taioli, M. van Gerwen, M. Mihalopoulos, et al., J. Thorac. Dis., 9(12), 5423 – 5433 (2017).CrossRefGoogle Scholar
  6. 6.
    M. Zamboni, C. T. da Silva Jr., R. Baretta, et al., BMC Pulm. Med., No. 15, 29 (2015).Google Scholar
  7. 7.
    J. Kim, S. Bhagwandin, and D. M. Labow, Ann. Transl. Med., 5(11), 236 (2017).CrossRefGoogle Scholar
  8. 8.
    N. I. Perevodchikova and T. R. Alekseeva, Mezhdunar. Med. Zh., No. 4, 88 – 93 (2003).Google Scholar
  9. 9.
    W. Zhang, X. Wu, L. Wu, et al., Ann. Transl. Med., 3(13), 182 (2015).Google Scholar
  10. 10.
    E. Mery, J. Hommell-Fontaine, M. Capovilla, et al., Ann. Pathol., No. 34, 26 – 33 (2014).Google Scholar
  11. 11.
    S. Liu, P. Staats, M. Lee, et al., Pathology, No. 46, 604 – 609 (2014).Google Scholar
  12. 12.
    A. U. Blackham, P. Shen, J. H. Stewart, et al., Ann. Surg. Oncol., No. 17, 2720 – 2727 (2010).Google Scholar
  13. 13.
    P. Yousefpour, F. A. Ebrahim, V. F. Ramin, et al., Int. J. Nanomed., No. 6, 1487 – 1496 (2011).Google Scholar
  14. 14.
    Y. Jeong, D. H. Kim, C.-W. Chung, et al., Int. J. Nanomed., No. 6, 1415 – 1427 (2011).Google Scholar
  15. 15.
    Y. Chen, R. K. McCulloch, and B. N. Gray, J. Controlled Release, No. 31, 49 – 54 (1994).Google Scholar
  16. 16.
    M. Yu. Revtovich, P. M. Bychkovskii, T. L. Yurkshtovich, et al., Ross. Bioterapevticheskii Zh., No. 16(S), 64 – 66 (2017).Google Scholar
  17. 17.
    N. A. Pyataev, A. A. Kladiev, A. V. Kokorev, et al., Sovrem. Probl. Nauki Obraz., No. 5, 352 (2013).Google Scholar
  18. 18.
    A. V. Zaborovskii, L. A. Tararina, A. G. Mulyar, et al., Sist. Anal. Upr. Biomed. Sist., 15(3), 401 – 403 (2016).Google Scholar
  19. 19.
    N. A. Pyataev, K. G. Gurevich, A. V. Zaborovskii, et al., Khim.-farm. Zh., 48(11), 18 – 22 (2014).Google Scholar
  20. 20.
    N. A. Pyataev, P. S. Petrov, et al., RU Pat. 2,629,608, Aug. 30, 2017; Byull. Izobret., No. 25 (2016)Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • O. V. Minaeva
    • 1
  • A. V. Kokorev
    • 2
  • P. S. Petrov
    • 1
  • O. A. Kulikov
    • 1
  • A. V. Zaborovskii
    • 3
    Email author
  • K. G. Gurevich
    • 3
  • L. A. Tararina
    • 3
  • D. V. Yunina
    • 3
  • A. M. Fedina
    • 3
  • E. V. Gromova
    • 1
  • M. N. Zharkov
    • 1
  • E. P. Brodovskaya
    • 1
  • N. A. Pyataev
    • 1
  1. 1.N. P. Ogarev Mordovia State UniversitySaranskRussia
  2. 2.Obninsk Institute for Nuclear Power EngineeringNational Research Nuclear University MEPhI (Moscow Engineering Physics Institute)ObninskRussia
  3. 3.A. I. Evdokimov Moscow State University of Medicine and DentistryMinistry of Health of the RFMoscowRussia

Personalised recommendations